(MedPage Today) -- An FDA advisory committee voted Thursday to remove compounding restrictions on two peptides -- BPC-157 and KPV -- despite little evidence the products are safe or effective for medical use. BPC-157, touted by wellness influencers...
FDA Panel Narrowly Backs Lifting Restrictions on Peptides Backed by RFK Jr.